Stereotactic
Cyberknife based radiotherapy
in Liege
introduction
possible dosimetric comparisons
?
Nicolas Jansen April 2011
• From simple to complex
• From medium dose to ultra high dose
• From large volumes to small volumes
• From unefficient to very efficient ?
• From surgery to radiotherapy ??
• From cheap to expensive ??? (or …)
The pendulum swings …
Acta Oncol. 1995;34(6):861-70. Stereotactic high dose fraction radiation therapy of extracranial tumors using an
accelerator. Clinical experience of the first thirty-one patients.
Blomgren H et al. Karolinska Hospital, Stockholm, Sweden
Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):449-57. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms.
Nakagawa K et al. University of Tokyo, Tokyo, Japan Rapid
introduction in clinical
practice
In
Belgium ?
Curr Probl Cancer. 2003 Jan-Feb;27(1):60-3.
New potentials of radiotherapy in non-small cell lung cancer: stereotactic therapy and IMRT. Van Houtte P. Radiation Department, Institute Jules Bordet, Brussel
J Vasc Interv Radiol. 2005 Jan;16(1):51-6. Percutaneous placement of marking coils before stereotactic radiation therapy of malignant lung lesions. de Mey J et al.
Department of Radiology, UZ Brussel
Cancer Radiother. 2010 Oct;14(6-7):446-54 Gating and tracking, 4D in thoracic tumours. Verellen D et al. Department of Radiotherapy, UZ Brussel
Int J Radiat Oncol Biol Phys. 2010 Aug 12. Prospective, Risk-Adapted
Strategy of Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: Results of a Phase II Trial. Bral S, et al. Department of
Radiotherapy, UZ Brussel
Example for lung SRS …
• Assessment of the uncertainties in dose delivery of a commercial system for
linac-based stereotactic radiosurgery - Verellen D, et al. - Int J Radiat Oncol Biol Phys. 1999-5 1;44(2):421-33
Are there any quality differences in
stereotactic radiotherapy approaches ?
• Differences based on …
– Experience
– Internal workflow and quality control
– Technical differences in treatment delivery
system
• Beam characteristics • Tracking capabilities • …
What are the different systems for
stereotactic radiotherapy delivery ?
• Stereotactic placement of sources for
prostate brachytherapy
• (Very conformal treatments)
• Classical linac based (Novalis)
• Tomotherapy based systems
• Purpose build stereotactic devices with
inherent 4D capabilities
– Vero
• Comparison of stereotactic approaches
– Ideally : clinical outcome based (long time effort)
• Narrow comparison : between stereotactic systems
• Wider comparison : Stereotactic radiotherapy versus … protontherapy, surgery, targeted systemic therapies, …
– Dosimetric comparison
• Narrow comparison : between stereotactic devices
• Wider comparison : stereotactic systems relative to a more ‘classical approach’ to be able to justify the
Comparing radiotherapy approaches
• Clinical outcome
• Dosimetric
• Time
• Cost
• Availability
• Acceptability
Comparing radiotherapy approaches
• Clinical outcome
• Dosimetric
• Time
• Cost
• Availability
• Acceptability
Dosimetric comparison
• How to compare ?
– For each OAR : different DVH parameters – For the PTV : the coverage, … (indices)
• But cheating is possible
– (Forgetting) margin management – Look only at high dose regions
Dosimetric comparison
• How to compare plan results ?
– DVH comparison
• Curve form
• Key DVH parameters
– DVH indices
– Dose distribution itself
Dosimetric comparison
• How to compare plan results ?
– DVH comparison
• Curve form
• Key DVH parameters
– DVH indices
– Dose distribution itself
Dosimetric comparison
• How to compare plan results ?
– DVH comparison
• Curve form
• Key DVH parameters
– DVH indices
– Dose distribution itself
Dosimetric comparison
• DVH derived parameters
– Validated for stereotatic treatments ? – Are they clinically relevant ?
• Which ones do we want to analyse ?
– Single point constraints/limits
• Vx • Dx
– Mathematically derived parameters
• CI, DHI,
– Tumor response models
• Lyman NTCP model
• Local Radiation Response - Organ Functional Reserve Models
Dosimetric comparison
• DVH derived parameters
– Validated for stereotatic treatments ? – Are they clinically relevant ?
• Which ones do we want to analyse ?
– Single point constraints/limits
• Vx • Dx
– Mathematically derived parameters
• CI, DHI,
– Tumor response models
• Lyman NTCP model
• Local Radiation Response - Organ Functional Reserve Models
DVH parameters
• CI :
– V
ref isodose/ V
target volume– Conformity index
– A ratio of VOLUMES
– Ideally CI = 1
– RTOG radiosurgery quality guidelines :
• CI = 1.0 to 2.0
• CI = 0.9 to 1.0 or 2.0 to 2.5 : minor deviation • CI < 0.9 or CI > 2.5 : major deviation
DVH parameters
• CI :
– Min isodose surrounding the target / Reference isodose
– Coverage index
– A ratio of DOSES
– Ideally 100%
– RTOG radiosurgery quality guidelines :
• CI > 90% : adequate
• CI 80% to 90% : minor deviation • CI < 80% : major deviation
DVH parameters
• HI :
– Max isodose in the target / Reference isodose
– Homogeneity Index
– A ratio of DOSES
– Ideally HI = 1 ?
NO, if hot spots are inside the GTV– RTOG radiosurgery quality guidelines :
• HI 1.0 to 2.0 : adequate
• HI 2.0 to 2.5 : minor deviation • HI > 2.5 : major deviation
Dosimetric comparison
• Pre-analysis standardisation
– Equal image set used – Identical GTV-CTV
– Identical dose and fractionation
• But …
– Not all systems require the same immobilisation – Different treatment execution errors and different
tracking parameters can induce different … margins
Margins …
• Reflect the imprecisions and errors of the whole
treatment preparation and delivery chain
• GTV to CTV : should be identical
• CTV to PTV : to be re analysed for each technique
• Are a source of … errors
– Unrealistic margins
– Should be adapted to … new imprecisions
• Marker tracking • …
Ablative dose, no ablative results
• If the dose is ablativen why is the LC after the
treatment not 100%
– The staging was incomplete or inaccurate
– The dose is not ablative because of radioresistance
What do we know about comparisons in
stereotactic radiotherapy ?
• First data
– Dosimetric comparison of stereotactic radiosurgery to intensity modulated radiotherapy - Kramer BA, Wazer DE, Engler MJ, Tsai JS, Ling MN - Radiat Oncol Investig. 1998;6(1):18-25.
– Dosimetric comparison of stereotactic body radiotherapy in different respiration
conditions: a modeling study - Kontrisova K, Stock M, Dieckmann K, Bogner J, Pötter R, Georg D - Radiother Oncol. 2006 Oct;81(1):97-104
– Dosimetric comparison of linear accelerator-based stereotactic radiosurgery systems - Sharma SD, Kumar S, Dagaonkar SS, Bisht G, Dayanand S, Devi R,
What do we know about comparisons ?
• Not cyberknife related : hot topic last 6 months!
– Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation
for Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer - Sher DJ, Wee JO, Punglia
RS - Int J Radiat Oncol Biol Phys. 2011 Feb 10
– Comparison of stereotactic brachytherapy (125 iodine seeds) with stereotactic radiosurgery
(LINAC) for the treatment of singular cerebral metastases - Ruge MI, Kocher M, Maarouf M,
Hamisch C, Treuer H, Voges J, Sturm V - Strahlenther Onkol. 2011 Jan;187(1):7-14
– Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated
arc therapy with 3 other delivery techniques - Ong CL, Verbakel WF, Cuijpers JP, Slotman BJ,
Lagerwaard FJ, Senan S - Radiother Oncol. 2010 Dec;97(3):437-42
– Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated
stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial - Combs SE, Burkholder I, Edler L, Rieken S, Habermehl D, Jäkel O, Haberer T, Haselmann R,
Unterberg A, Wick W, Debus J - BMC Cancer. 2010 Oct 6;10:533
– Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for
non-small-cell lung cancer - Kadoya N, Obata Y, Kato T, Kagiya M, Nakamura T, Tomoda T, Takada
A, Takayama K, Fuwa N - Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1225-31
– Dosimetric comparison of intensity-modulated stereotactic radiotherapy with other
stereotactic techniques for locally recurrent nasopharyngeal carcinoma - Kung SW, Wu VW,
Kam MK, Leung SF, Yu BK, Ngai DY, Wong SC, Chan AT - Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):71-9.
What do we know about comparisons ?
• Cyberknife related
– A dosimetric comparison between Gamma Knife and CyberKnife treatment plans for trigeminal neuralgia - Descovich M, Sneed PK, Barbaro NM, McDermott MW, Chuang CF, Barani IJ, Nakamura JL, Lijun M - J Neurosurg. 2010 Dec;113 Suppl:199-206 (University of California, San Francisco)
– A dosimetric comparison of stereotactic body radiation therapy techniques for lung cancer: robotic versus conventional linac-based systems - Ding C, Chang CH, Haslam J, Timmerman R, Solberg T - J Appl Clin Med Phys. 2010 Jun 29;11(3):3223 (University of Texas Southwestern Medical Center, Dallas) – Intracranial radiosurgery in the Netherlands. A planning comparison of available systems with
regard to physical aspects and workload - Schoonbeek A, Monshouwer R, Hanssens P, Raaijmakers E, Nowak P, Marijnissen JP, Lagerwaard FJ, Cuijpers JP, Vonk EJ, van der Maazen RW - Technol Cancer Res Treat. 2010 Jun;9(3):279-90 (Radboud University Nijmegen Medical Centre, Nijmegen)
– Quality of radiosurgery for single brain metastases with respect to treatment technology: a matched-pair analysis - Wowra B, Muacevic A, Tonn JC. - J Neurooncol. 2009 Aug;94(1):69-77 –(European
CyberKnife Center Munich)
– Comparison of advanced irradiation techniques with photons for benign intracranial tumours - Cozzi L, Clivio A, Bauman G, Cora S, Nicolini G, Pellegrini R, Vanetti E, Yartsev S, Fogliata A - Radiother Oncol. 2006 Aug;80(2):268-73 (Oncology Institute of Southern Switzerland, Medical Physics, Bellinzona,
Switzerland )
– Dosimetric comparison of CyberKnife with other radiosurgical modalities for an ellipsoidal target - Yu C, Jozsef G, Apuzzo ML, Petrovich Z - Neurosurgery. 2003 Nov;53(5):1155-62 (University of Southern California, Los Angeles)
A dosimetric comparison between Gamma Knife and CyberKnife treatment plans for trigeminal neuralgia - Descovich M, Sneed PK, Barbaro NM, McDermott
MW, Chuang CF, Barani IJ, Nakamura JL, Lijun M - J Neurosurg. 2010 Dec;113 Suppl:199-206 (University of California, San Francisco)
Discussion : what treatment planning efforts have been done ?
A dosimetric comparison of stereotactic body radiation therapy techniques for lung cancer: robotic versus conventional linac-based systems - Ding C, Chang
CH, Haslam J, Timmerman R, Solberg T - J Appl Clin Med Phys. 2010 Jun 29;11(3):3223 (University of Texas Southwestern Medical Center, Dallas)
• n=8 / common contours / 3x20 Gy
• 4D CT scan → MIP creation
• PTV 3D created, also PTV 4D
A 4D CT scanning is performed. A 3D conformal linac- SBRT plan is designed on ITV and
corresponding PTV 3D.
A deformable registration method is then applied to obtain the 4D cumulative dose distribution.
GTV and PTV 4D are contoured on the 50% phase of 4D CT
images, which corresponds to the maximum exhalation.
The 50% phase of 4D CT images and contour sets of GTV and
PTV 4D are sent to CyberKnife system for Synchrony planning.
CI = conformity index =
the ratio of the tissue volume receiving the prescription isodose or more to the tumor volume
Intracranial radiosurgery in the Netherlands. A planning comparison of available systems with regard to physical aspects and workload - Schoonbeek A, Monshouwer R, Hanssens P, Raaijmakers E, Nowak P, Marijnissen JP, Lagerwaard FJ, Cuijpers JP, Vonk EJ,
van der Maazen RW - Technol Cancer Res Treat. 2010 Jun;9(3):279-90 (Radboud University Nijmegen Medical Centre, Nijmegen)
• 5 systems – CK – Gammaknife – Novalis 3 mm leafs – Tomotherapy – Linac 10 mm leafs
• GTV + 2 mm = PTV (fixed for all systems) • N = 5 patients (skull base tumors)
– 3 size levels
• 3 target volumes
– 0.1 ml : no system can respect the
conformality index (all >3.0)
– 0.5 ml : better for CK, GK
Quality of radiosurgery for single brain metastases with respect to treatment technology: a matched-pair analysis - Wowra B, Muacevic A, Tonn JC. - J
Neurooncol. 2009 Aug;94(1):69-77 –(European CyberKnife Center Munich)
• With a matched-pair analysis we were able to prove that identical quality of clinical results in single brain metastases can be achieved with the GK and the CK. • Furthermore we could show that the radiosurgical
dose can be better tailored to the target with the CK than with the GK.
• This result, a more homogeneous dose distribution, and a lower peripheral dose represent an advantage of the CK in regard of the radiation protection
Comparison of advanced irradiation techniques with photons for benign intracranial tumours - Cozzi L, Clivio A, Bauman G, Cora S, Nicolini G, Pellegrini R, Vanetti E, Yartsev S,
Fogliata A - Radiother Oncol. 2006 Aug;80(2):268-73 (Oncology Institute of Southern Switzerland, Medical Physics, Bellinzona, Switzerland )
AMOA = intensity modulated arc therapy HT = helical thomotherapy
Dosimetric comparison of CyberKnife with other radiosurgical modalities for an ellipsoidal target - Yu C, Jozsef G, Apuzzo ML, Petrovich Z - Neurosurgery.